Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Irene Agodoa"'
Autor:
William B. Ershler, MD, Laura M. De Castro, MD, MHSc, Zahra Pakbaz, MD, Aaron Moynahan, MA, Derek Weycker, PhD, Thomas E. Delea, MSIA, Irene Agodoa, MD, Ze Cong, PhD
Publikováno v:
Current Therapeutic Research, Vol 98, Iss , Pp 100696- (2023)
ABSTRACT: Background: Sickle cell disease (SCD) is an inherited, chronic, multifaceted blood disorder. Patients with SCD develop anemia, which has been associated with end-organ damage (EOD). Objectives: This retrospective, observational, repeated-me
Externí odkaz:
https://doaj.org/article/525589fc430748bca4276d0196e5e467
Autor:
Kenneth I Ataga, Victor R Gordeuk, Irene Agodoa, Jennifer A Colby, Kimberly Gittings, Isabel E Allen
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0229959 (2020)
Sickle cell disease (SCD) is characterized by deoxygenation-induced polymerization of hemoglobin in red blood cells, leading to hemolytic anemia, vaso-occlusion, and the development of multiple clinical complications. To characterize the clinical bur
Externí odkaz:
https://doaj.org/article/0f29881b941e4fd5bf2498c98cd112fa
Autor:
Paul Telfer, Irene Agodoa, Kathleen M. Fox, Laurie Burke, Timothy Mant, Marzena Jurek, Margaret Tonda, Josh Lehrer-Graiwer
Publikováno v:
Hematology Reports, Vol 10, Iss 2 (2018)
For many patients with sickle cell disease (SCD), jaundice is a significant clinical disease manifestation that impacts on patient well-being. We report a case of a patient with SCD and chronic jaundice treated with voxelotor (GBT440), a novel small
Externí odkaz:
https://doaj.org/article/5a6a888f058a4f77855c543547925246
Publikováno v:
Journal of Osteoporosis, Vol 2015 (2015)
Purpose. To evaluate the cost-effectiveness of denosumab versus other osteoporotic treatments in older men with osteoporosis from a US payer perspective. Methods. A lifetime cohort Markov model previously developed for postmenopausal osteoporosis (PM
Externí odkaz:
https://doaj.org/article/2c819bd5149945ddbd854ee449e187e9
Autor:
Jane S. Hankins, Juan Ding, M. Beth McCarville, Ze Cong, Jeremie H. Estepp, Guolian Kang, Irene Agodoa, Winfred C. Wang
Publikováno v:
British Journal of Haematology. 194:463-468
Children with sickle cell anaemia (SCA) and conditional transcranial Doppler (TCD) flow velocities (conditional: 170-199 cm/s; normal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0541270e1498ad18272408d1bd7dc726
https://doi.org/10.1111/bjh.17620
https://doi.org/10.1111/bjh.17620
Autor:
Maureen Achebe, Sarah Gray, Kenneth I. Ataga, Hoda Hassab, Amal El-Beshlawy, Elliott Vichinsky, Margaret Tonda, Videlis Nduba, Irene Agodoa, Jo Howard, Robert Clark Brown, Joshua Lehrer-Graiwer
Publikováno v:
The Lancet Haematology. 8:e323-e333
For decades, patients with sickle cell disease have had only a limited number of therapies available. In 2019, voxelotor (1500 mg), an oral once-daily sickle haemoglobin polymerisation inhibitor, was approved in the USA for the treatment of sickle ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f9f65fcf8ec26745fd1e15dc57df93b
https://doi.org/10.1016/s2352-3026(21)00059-4
https://doi.org/10.1016/s2352-3026(21)00059-4
Autor:
Richard T. Maziarz, Steven M Devine, Louis P. Garrison, Irene Agodoa, Jack Badaracco, Matthew Gitlin, Miguel-Angel Perales
Publikováno v:
Blood. 140:10833-10834
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4674628d7f9bcdfbad78d318e1d71a1c
https://doi.org/10.1182/blood-2022-157439
https://doi.org/10.1182/blood-2022-157439
Autor:
Nirmish Shah, Thokozeni Lipato, Ofelia Alvarez, Thomas Delea, Alexander Lonshteyn, Derek Weycker, Andy Nguyen, Anne Beaubrun, Irene Agodoa
Publikováno v:
Expert review of hematology. 15(2)
Sickle cell disease (SCD) is a genetic disease that impacts patients' quality of life, healthcare costs, and life expectancy. Elevated sickle hemoglobin (HbS), which readily polymerizes, causes red blood cell sickling, leading to chronic hemolytic an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e366d9b3ec1686c7bb3e8d441205d2b9
https://pubmed.ncbi.nlm.nih.gov/35191358
https://pubmed.ncbi.nlm.nih.gov/35191358
Autor:
Irene Agodoa, Victor R. Gordeuk, Kenneth I. Ataga, Jennifer A. Colby, Isabel E. Allen, Kimberly Gittings
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0229959 (2020)
PloS one, vol 15, iss 4
PLoS ONE
PloS one, vol 15, iss 4
PLoS ONE
Sickle cell disease (SCD) is characterized by deoxygenation-induced polymerization of hemoglobin in red blood cells, leading to hemolytic anemia, vaso-occlusion, and the development of multiple clinical complications. To characterize the clinical bur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945dafa1c27ebcc1c3d7ebedccd74617
https://doaj.org/article/0f29881b941e4fd5bf2498c98cd112fa
https://doaj.org/article/0f29881b941e4fd5bf2498c98cd112fa
Autor:
Vania Munaretto, Claudio Baracchini, Irene Agodoa, Alessandra Biffi, Laura Sainati, Renzo Manara, Giulia Reggiani, Federica Viaro, Raffaella Colombatti, Anne Beaubrun, Beatrice Coppadoro, Alessio Pieroni
Publikováno v:
Blood. 138:3092-3092
Background: Children with sickle cell disease (SCD) are at increased risk of cerebrovascular events that can impact neurocognitive development and quality of life (Colombatti 2016). Transcranial Doppler ultrasound (TCD) is a validated screening tool
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61af4fb62c2779efd644c0658abc1254
https://doi.org/10.1182/blood-2021-148043
https://doi.org/10.1182/blood-2021-148043